NCT00524381View on ClinicalTrials.gov

Etanercept Treatment in the Early Course of Polymyalgia Rheumatica

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

September 30, 2009

Conditions
Polymyalgia Rheumatica
Interventions
DRUG

Etanercept (Enbrel)

TNF-alpha antagonist, subcutaneous injection, 25 mg twice/week, 14 days.

DRUG

Sodium chloride (placebo)

NaCl, isotonic saline, subcutaneous injection, 1 ml twice/week, 14 days.

Trial Locations (1)

DK-2400

Bispebjerg Hospital, Department of Rheumatology, Copenhagen NV

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT00524381 - Etanercept Treatment in the Early Course of Polymyalgia Rheumatica | Biotech Hunter | Biotech Hunter